New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
VolitionRx Limited
VNRX
Shape
US Flag

AMEX

Unprofitable

EPS improving

Unprofitable

EPS improving

64M

Medical - Diagnostics & Research

Next Earning date - 12 Nov 2024

64M

Medical - Diagnostics & Research

Next Earning date - 12 Nov 2024

0.69USD
Shape-0.01 ( -1.07%)
favorite-chart

Relative Strenght

2
favorite-chart

Volume Buzz

-68%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

44%

Quote Panel

Shape
Updated October 12, 2024
1W -11.78 % 1M 1.90 % 3M 4.92 % 1Y 4.92 %

Key Metrics

Shape
  • Market Cap

    63.78M


  • Shares Outstanding

    92.10M


  • Share in Float

    69.75M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    0.6925


  • Average Volume

    145056


  • Beta

    1.098


  • Range

    0.43-1.23


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.volition.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

65.31x

P/S Ratio

-2.63x

P/B Ratio

-0.2

Debt/Equity

-3320.1%

Net Margin

$-0.4

EPS

How VNRX compares to sector?

P/E Ratio

Relative Strength

Shape

VNRX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$14M

Shape3450%

2025-Revenue

$0.17

Shape-95%

2025-EPS

$14M

Shape-111%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.14
vs -0.13

Q4.22

arrow
arrow

N/A

-0.13
vs -0.15

Q1.23

arrow
arrow

N/A

-0.15
vs -0.14

Q2.23

arrow
arrow

N/A

-0.14
vs -0.14

Q3.23

arrow
arrow

N/A

-0.11
vs -0.14

Q4.23

arrow
arrow

N/A

-0.11
vs -0.13

Q1.24

arrow
arrow

N/A

-0.10
vs -0.15

Q2.24

arrow
arrow

N/A

-0.08
vs -0.14

Q3.24

arrow
arrow

N/A

-0.08
vs -0.11

Q4.24

arrow
arrow

N/A

-0.07
vs -0.11

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+28%

32.7K  vs 25.5K

Q4.22

arrow
arrow

+741%

119.7K  vs 14.2K

Q1.23

arrow
arrow

+31%

149.8K  vs 114.2K

Q2.23

arrow
arrow

+444%

216.3K  vs 39.8K

Q3.23

arrow
arrow

+405%

165.2K  vs 32.7K

Q4.23

arrow
arrow

+104%

244K  vs 119.7K

Q1.24

arrow
arrow

+15%

171.5K  vs 149.8K

Q2.24

arrow
arrow

+83%

395.8K  vs 216.3K

Q3.24

arrow
arrow

+295%

652K  vs 165.2K

Q4.24

arrow
arrow

+316%

1M  vs 244K

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-235%

-2.35
vs -1.71

Q4.22

arrow
arrow

+281%

2.81
vs -2.35

Q1.23

arrow
arrow

+376%

3.76
vs 2.81

Q2.23

arrow
arrow

-162%

-1.62
vs 3.76

Q3.23

arrow
arrow

+410%

4.1
vs -1.62

Q4.23

arrow
arrow

+111%

1.11
vs 4.1

Q1.24

arrow
arrow

+54%

0.54
vs 1.11

Q2.24

arrow
arrow

+32%

0.32
vs 0.54

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

33

33
vs 34

-3%

Q4.22

arrow
arrow

39

39
vs 33

18%

Q1.23

arrow
arrow

43

43
vs 39

10%

Q2.23

arrow
arrow

38

38
vs 43

-12%

Q3.23

arrow
arrow

31

31
vs 38

-18%

Q4.23

arrow
arrow

29

29
vs 31

-6%

Q1.24

arrow
arrow

24

24
vs 29

-17%

Q2.24

arrow
arrow

29

29
vs 24

21%

Earnings Growth

Latest News